Quantitative- and Phospho-Proteomic Analysis of the Yeast Response to the Tyrosine Kinase Inhibitor Imatinib to Pharmacoproteomics-Guided Drug Line Extension-Reference-Cited by-同舟云学术

Quantitative- and Phospho-Proteomic Analysis of the Yeast Response to the Tyrosine Kinase Inhibitor Imatinib to Pharmacoproteomics-Guided Drug Line Extension

Published:2012-10 Issue:10 Volume:16 Page:537-551
ISSN:1536-2310
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

dos Santos Sandra C.¹,Mira Nuno P.¹²,Moreira Ana S.¹,Sá-Correia Isabel¹²

Affiliation:

1. Institute for Biotechnology and Bioengineering (IBB), Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Technical University of Lisbon, Lisbon, Portugal.

2. Department of Bioengineering, Instituto Superior Técnico, Technical University of Lisbon, Lisbon, Portugal.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/omi.2012.0012

Reference84 articles.

1. YEASTRACT: providing a programmatic access to curated transcriptional regulatory associations in Saccharomyces cerevisiae through a web services interface

2. Development of a simplified, economical polyacrylamide gel staining protocol for phosphoproteins

3. Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

4. Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia

5. Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL–positive leukemias identified by a proteomics approach

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis and Interpretation of Pharmacoproteomic Data;Pharmacoproteomics;2024

2. Analytical Methods in Pharmacoproteomics: A Systematic Review;Pharmacoproteomics;2024

3. Alterations in cellular metabolisms after Imatinib therapy: a review;Medical Oncology;2022-05-16

4. Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review;Molecular and Cellular Biochemistry;2022-02-07

5. Integration of fluxome and transcriptome data in Saccharomyces cerevisiae offers unique features of doxorubicin and imatinib;Molecular Omics;2021